Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours 
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
FOR IMMEDIATE RELEASE
Fort Lauderdale, FL, May 07, 2018 -- OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, today announced the launch of OmniComm AutoEncoder, a user-friendly tool for coding clinical data against medical dictionaries. OmniComm will showcase and demonstrate AutoEncoder at industry events around the globe, including Innovation Forum Europe, June 7-8 in Bonn, DIA China in Beijing on May 23-25, and DIA 2018 in Boston on June 24-28.
“We have taken the opportunity to build a state-of-the-art coding tool from scratch,” said Keith Howells, OmniComm’s chief technology officer. “It has sophisticated algorithms, including language-sensitive search capabilities, and it features a fresh, intuitive and responsive user interface. Coding professionals are going to feel really at home with this product.”
Coding is a unique and necessary process required by regulators during clinical trials or when monitoring the safety of approved products. Regulatory agencies require that adverse events be coded against the MedDRA dictionary, and that medications be coded against the WHO Drug dictionary. The coding process is performed by specialist medical professionals, who must ensure consistent and accurate decisions based on the content of the source term, any relevant related data, and prior decisions for the trial or drug project.
The OmniComm AutoEncoder provides a modern and sophisticated tool for performing these coding activities. Out of the box, AutoEncoder is fully integrated with OmniComm’s TrialMaster® product for Electronic Data Capture, and its open interfaces also allow for integration with any third-party EDC or safety reporting system.
“We are confident that our cutting-edge coding solution will be well received by the industry,” said Stephen Johnson, president and CEO of OmniComm. “AutoEncoder deploys the latest in technology and intuitive design. We’ve leveraged our previous 10 years of experience offering coding solutions and aligned this new technology to match the changing industry regulations. The result is a functionally rich, easy-to-use, innovative solution that is fully integrated with our TrialMaster EDC solution and easily integrated with third-party EDC and safety systems.”
About OmniComm Systems, Inc.
OmniComm Systems provides a role in enhancing patient lives by shortening time to market of essential life-saving treatments. OmniComm Systems is dedicated to providing the latest eClinical technology enabling the world’s life science organizations to maximize the value of their clinical research investments. OmniComm’s solutions provide better trial oversight and study delivery, connecting patients to better healthcare. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information.
Trademarks
OmniComm, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post OmniComm Systems, Inc. +1.954.473.1254 [email protected]
